Uncategorized
As lawsuits climb, J&J may have new hip trauma
CHICAGO (Reuters) - Johnson & Johnson faces a potentially more damaging and costly sequel
to the $3 billion recall of its ASR all-metal artificial hips two years ago, one of the most expensive medical
device failures in U.S. history.